Drug Profile
Research programme: bombesin receptor agonists - Amgen
Latest Information Update: 06 Apr 2011
Price :
$50
*
At a glance
- Originator Amgen
- Class Small molecules
- Mechanism of Action Bombesin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Obesity
Most Recent Events
- 19 Nov 2008 Preclinical trials in Obesity in USA (PO)